Drug Profile
Albaconazole - AbbVie/Stiefel Laboratories
Alternative Names: UR-9825; W 0027Latest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Uriach
- Developer Stiefel Laboratories
- Class Antifungals; Chlorobenzenes; Fluorobenzenes; Quinazolinones; Small molecules; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Tinea pedis
- Discontinued Chagas disease; Mycoses; Onychomycosis; Vulvovaginal candidiasis